Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening

Highlights • Anyplex ™ II HPV HR Detection is clinically non-inferior to GP5+/6+-PCR. • Intra- and inter-laboratory agreement of Anyplex ™ II HPV HR Detection are high. • Anyplex ™ II HPV HR Detection complies with international guidelines for HPV DNA tests.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical virology 2016-03, Vol.76, p.36-39
Hauptverfasser:	Hesselink, A.T, Sahli, R, Berkhof, J, Snijders, P.J.F, van der Salm, M.L, Agard, D, Bleeker, M.C.G, Heideman, D.A.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergy and Immunology Alphapapillomavirus - genetics Alphapapillomavirus - isolation & purification Cervical Intraepithelial Neoplasia - diagnosis Cervical Intraepithelial Neoplasia - prevention & control Cervical Intraepithelial Neoplasia - virology CIN2/3 Colposcopy Early Detection of Cancer - methods Female Genotype HPV Human papillomavirus 16 Human papillomavirus 18 Humans Infectious Disease Mass Screening Middle Aged Papillomavirus Infections - diagnosis Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Pregnancy Primary cervical cancer screening Reagent Kits, Diagnostic Real-Time Polymerase Chain Reaction Reproducibility of Results Republic of Korea Sensitivity and Specificity Test requirements Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Anyplex ™ II HPV HR Detection is clinically non-inferior to GP5+/6+-PCR. • Intra- and inter-laboratory agreement of Anyplex ™ II HPV HR Detection are high. • Anyplex ™ II HPV HR Detection complies with international guidelines for HPV DNA tests.
ISSN:	1386-6532 1873-5967
DOI:	10.1016/j.jcv.2016.01.009